Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 8:01 PM View:  | Henderson Michael Thomas Chief Executive Officer Director | Apogee Therapeutics, Inc. (APGE) | 02-Oct-24 | Sale (Planned) | 40,000 | $56.23 | $2,249,310.00 | (3%) 1.39M to 1.35M | |
| 04-Oct-24 8:02 PM View: | Dambkowski Carl Chief Medical Officer | Apogee Therapeutics, Inc. (APGE) | 02-Oct-24 | Sale (Planned) | 6,665 | $56.26 | $374,954.00 | (2%) 280.79K to 274.13K | |
| 06-Sep-24 8:02 PM View: | Henderson Michael Thomas Chief Executive Officer Director | Apogee Therapeutics, Inc. (APGE) | 04-Sep-24 | Sale (Planned) | 40,000 | $47.62 | $1,904,840.00 | (3%) 1.43M to 1.39M | |
| 06-Sep-24 8:03 PM View: | Dambkowski Carl Chief Medical Officer | Apogee Therapeutics, Inc. (APGE) | 04-Sep-24 | Sale (Planned) | 6,665 | $47.56 | $316,969.00 | (2%) 287.46K to 280.79K | |
| 23-Aug-24 8:05 PM View: | Henderson Jane Chief Financial Officer | Apogee Therapeutics, Inc. (APGE) | 23-Aug-24 | Sale | 6,000 | $48.26 | $289,560.00 | (3%) 206.87K to 200.87K | |
| 09-Aug-24 8:05 PM View: | Henderson Michael Thomas Chief Executive Officer Director | Apogee Therapeutics, Inc. (APGE) | 07-Aug-24 | Sale (Planned) | 40,000 | $40.62 | $1,624,760.00 | (3%) 1.47M to 1.43M | |
| 09-Aug-24 8:05 PM View: | Dambkowski Carl Chief Medical Officer | Apogee Therapeutics, Inc. (APGE) | 07-Aug-24 | Sale (Planned) | 7,335 | $40.67 | $298,336.00 | (2%) 294.79K to 287.46K | |
| 05-Jul-24 8:01 PM View: | Henderson Michael Thomas Chief Executive Officer Director | Apogee Therapeutics, Inc. (APGE) | 05-Jul-24 | Sale (Planned) | 15,000 | $37.26 | $558,900.00 | (1%) 1.49M to 1.47M | |
| 05-Jul-24 8:01 PM View: | Dambkowski Carl Chief Medical Officer | Apogee Therapeutics, Inc. (APGE) | 03-Jul-24 | Sale (Planned) | 5,995 | $37.60 | $225,418.00 | (2%) 300.79K to 294.79K | |
| 01-Apr-24 5:44 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 28-Mar-24 | Disposition (other) | 55,913 | -- | -- | (3%) 2.21M to 2.15M | |
| 01-Apr-24 5:44 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 28-Mar-24 | Acquisition (other) | 55,913 | -- | -- | 3% 2.15M to 2.21M | |
| 31-Jan-24 4:31 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 29-Jan-24 | Acquisition (other) | 102,332 | -- | -- | 11% 892.53K to 994.86K | |
| 31-Jan-24 4:31 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 29-Jan-24 | Disposition (other) | 892,529 | -- | -- | (90%) 994.86K to 102.33K | |
| 17-Jul-23 8:00 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 13-Jul-23 | Purchase | 2,941,180 | $17.00 | $50,000,000.00 | 100% 0 to 2.94M | |
| 17-Jul-23 8:00 PM View: | Shah Nimish P Director | Apogee Therapeutics, Inc. (APGE) | 13-Jul-23 | Purchase | 1,750,000 | $17.00 | $29,750,000.00 | 100% 0 to 1.75M |
